Antonia Salud - Dissemin

Papers authored by Antonia Salud

This paper is made freely available by the publisher.

2014 Julen Fernandez-Plana, Carlos Pericay, Guillermo Quintero, Vicente Alonso, Antonieta Salud

, Miguel Mendez, Mercedes Salgado, Eugeni Saigi, Luis Cirera

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Download from link.springer.com

Carlos Fernandez-Martos, Gina Brown, Rafael Estevan, Antonieta Salud

, Clara Montagut, Joan Maurel, Maria Jose Safont, Jorge Aparicio, Jaime Feliu, Ruth Vera, Vicente Alonso, Javier Gallego, Marta Martin, Miguel Pera, Enrique Sierra and 5 other authors

Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial

Download from pericles-gcp.literatumonline.com

This paper was not found in any repository, but could be made available legally by the author.

Carlos Gomez-Martín, Fernando Lopez-Rios, Jorge Aparicio, Jorge Barriuso, Rocio García-Carbonero, Roberto Pazo, Fernando Rivera, Mercedes Salgado, Antonieta Salud

, Enrique Vázquez-Sequeiros, Florian Lordick

A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond

Upload

J. Feliu, A. Salud

, M. J. Safont, C. García Girón, J. Aparicio, R. Vera, O. Serra, E. Casado, M. Jorge, P. Escudero, C. Bosch, U. Bohn, R. Pérez Carrión, A. Carmona, V. Martínez Marín and 1 other authors

First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

Download from www.nature.com

Alberto Muñoz, Carles Pericay, Carlos García-Girón, Vicente Alonso, Rosario Dueñas, Luis Cirera, Fernando Rivera, Esther Falcó, Iñaki Alvarez Bustos, Antonieta Salud

Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer

Download from doi.org

Anna Novell, Montserrat Martínez-Alonso, Moises Mira, Jordi Tarragona, Antonieta Salud

, Xavier Matias-Guiu

Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

Upload

Maria Nabal, Concepción Palomar, M. Teresa Juvero, M. Teresa Taberner, Miguel León, Antonieta Salud

Sedación paliativa: situación actual y áreas de mejora

Upload

2013 Carlos Gomez-Martin, Jose Carlos Plaza, Roberto Pazo-Cid, Antonieta Salud

, Francesc Pons, Paula Fonseca, Ana Leon, Maria Alsina, Laura Visa, Fernando Rivera, Elena del Valle, M. Carmen Galan, M. Carmen Galan, Felipe Vilardell, Mar Iglesias and 11 other authors

Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

Download from doi.org

D. Marquez-Medina, A. Chachoua, A. Martin-Marco, A. M. Desai, V. Garcia-Reglero, A. Salud-Salvia

, F. Muggia

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?

Download from link.springer.com

Diego Márquez-Medina, Ariadna Gasol-Cudós, M. Teresa Taberner-Bonastre, Juan Carlos Samamé Pérez-Vargas, Antonieta Salud-Salvia

, Antonio Llombart-Cussac

Virus del papiloma humano en cáncer de pulmón no microcítico. Impacto de mutaciones del EGFR o respuesta a erlotinib

Upload

2012 Diego Marquez-Medina, Joel Salla-Fortuny, Antonieta Salud-Salvia

Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

Download from link.springer.com

2011 José María Vieitez, Rocío García-Carbonero, Jorge Aparicio, Jaime Feliu, Encarnación González-Flores, Enrique Grande, Teresa Pérez-Hoyos, Antonieta Salud

, Esperanza Torres, María Valero, Manuel Valladares-Ayerbes, Eduardo Díaz-Rubio

Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain

Download from link.springer.com

Miguel Nogué, Antonieta Salud

, Pilar Vicente, Antonio Arriví, Roca Jm, José María Roca, Ferran Losa, José Ponce, Safont Mj, María José Safont, Inmaculada Guasch, Isabel Moreno, Ana Ruiz, Carles Pericay, Study Group Avacross

Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study

Download from onlinelibrary.wiley.com

Silvia Bielsa, Paula Hernández, Francisco Rodriguez-Panadero, Teresa Taberner, Antonieta Salud

, José M. Porcel

Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions

Upload

2010 J. Feliu, M. J. Safont, A. Salud

, F. Losa, C. García-Girón, C. Bosch, P. Escudero, R. López, C. Madroñal, M. Bolaños, M. Gil, A. Llombart, J. Castro-Carpeño, M. González-Barón

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

Download from www.nature.com

Carlos Fernández-Martos, Carles Pericay, Jorge Aparicio, Antonieta Salud

, MariaJose Safont, Bertomeu Massuti

, Ruth Vera, Pilar Escudero, Joan Maurel, Eugenio Marcuello, Jose Luis Mengual, Eugenio Saigi, Rafael Estevan, Moises Mira, Sonia Polo and 5 other authors

Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study

Download from doi.org